PRZOOM - /newswire/ -
Amherst, NH, United States, 2011/04/12 - New report examines prefilled syringe market device segments and product data, and analyzes important therapeutic sectors - GreystoneAssociates.org.
Driven by improved device designs, a maturing supply chain infrastructure and broad acceptance of inherent patient and caregiver benefits, prefilled syringes will continue to grow at a double digit rate, climbing past four billion units worldwide in 2015, according to the latest estimates from Greystone Research Associates.
“Prefilled syringes continue to grow because they address factors that represent fundamental goals within the healthcare sector,” explains George Perros, Greystone Managing Director. “These factors, which include improved patient compliance and patient & caregiver safety, favor drug packaging and delivery options that avoid the need for drug handling and preparation steps – steps that can introduce dosing errors and needlestick injuries - prior to administration.” For biologics, the economics of prefilled syringes are straightforward given the unit cost of this class of drugs and the packaging efficiencies realized from eliminating the use of vials.
For specialty prefilled injection devices - a group that includes prefilled pen injectors, autoinjectors and needle-free injection devices – the ability to create product differentiation in the age of direct-to-consumer marketing and competition from generics provide incentives to consider this higher-cost option. Specialty device features such as multi-dose drug cartridges and integrated dose counters can improve ease-of-use for self-administration and create brand loyalty among consumers with chronic conditions.
More information on the growth of prefilled syringes can be found in a new and comprehensive report, researched and prepared by Greystone Research Associates. Prefillable Syringes: Devices, Therapeutics, Players, Markets and Prospects examines prefilled syringe market segments and product data, analyzes important therapeutic segments and examines key regulatory, economic and competitive factors that represent potential barriers to commercial success.
Greystone Research Associates (GreystoneAssociates.org) is a medical technology consulting firm focused on the areas of medical market strategy, product commercialization, venture development, and market research. Our market research publications are designed, researched and written to provide timely and insightful information and data on focused market segments, with the aim of providing market participants with the essential knowledge to refine and execute their marketing plans and financial targets.